Related Experiment Video

Updated: Jun 22, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction

Denise L Campbell-Scherer1, Lee A Green

  • 1University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada.

American Family Physician
|June 18, 2009
PubMed

Insights

Updated guidelines emphasize early reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Key recommendations include aspirin for symptomatic patients and cautious beta-blocker use, while avoiding NSAIDs to improve patient outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • The 2004 guideline for ST-segment elevation myocardial infarction (STEMI) management required an update.
  • Cardiovascular societies collaborated to provide current evidence-based recommendations.

Purpose of the Study:

  • To present an updated guideline for the management of patients with ST-segment elevation myocardial infarction.
  • To incorporate new evidence and clinical best practices into STEMI care.

Main Methods:

  • The guideline was developed through a collaborative effort by the American College of Cardiology, American Heart Association, and Canadian Cardiovascular Society.
  • Evidence was reviewed and synthesized to formulate recommendations.

Main Results:

  • Early recognition and prompt reperfusion therapy are crucial for STEMI management.
  • Aspirin is recommended for symptomatic patients; beta-blockers should be used cautiously due to potential risks.
  • Combination therapy with clopidogrel and aspirin is indicated post-STEMI.
  • NSAIDs and COX inhibitors should be avoided due to increased mortality risk.

Conclusions:

  • Adherence to updated guidelines can improve STEMI patient outcomes.
  • Primary and secondary prevention strategies are vital for reducing the overall burden of heart disease and preventing recurrent events.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...